{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 1.97, "exchange": "AMS", "shortName": "BenevolentAI", "longName": "BenevolentAI S.A.", "messageBoardId": "finmb_413708734", "exchangeTimezoneName": "Europe/Amsterdam", "market": "nl_market", "regularMarketTime": 1683205262, "regularMarketDayHigh": 1.97, "regularMarketDayRange": "1.97 - 1.97", "regularMarketDayLow": 1.97, "regularMarketVolume": 96, "regularMarketPreviousClose": 1.97, "fullExchangeName": "Amsterdam", "financialCurrency": "GBP", "regularMarketOpen": 1.97, "averageDailyVolume3Month": 1533, "averageDailyVolume10Day": 536, "fiftyTwoWeekLowChange": 0.14999998, "fiftyTwoWeekLowChangePercent": 0.08241757, "fiftyTwoWeekRange": "1.82 - 9.5", "fiftyTwoWeekHighChange": -7.5299997, "fiftyTwoWeekHighChangePercent": -0.79263157, "fiftyTwoWeekLow": 1.82, "fiftyTwoWeekHigh": 9.5, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.72, "sharesOutstanding": 117489000, "bookValue": 1.311, "fiftyDayAverage": 2.3062, "fiftyDayAverageChange": -0.3362, "fiftyDayAverageChangePercent": -0.14578094, "twoHundredDayAverage": 3.65065, "twoHundredDayAverageChange": -1.68065, "twoHundredDayAverageChangePercent": -0.46037006, "marketCap": 236378336, "priceToBook": 1.5026697, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "BenevolentAI soci\u00e9t\u00e9 anonyme", "nameChangeDate": "2023-05-14", "averageAnalystRating": "2.5 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1650870000000, "priceHint": 4, "regularMarketChange": 0.0, "symbol": "BAI.AS"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "4-8 Maple Street", "city": "London", "zip": "W1T 5HD", "country": "United Kingdom", "phone": "44 20 3781 9360", "website": "https://www.benevolent.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "BenevolentAI S.A. operates as a clinical-stage AI-enabled drug discovery and development company. Its BenevolentAI platform powers in-house drug pipeline of drug programs. The company's therapeutic areas, include atopic dermatitis, ulcerative colitis, amyotrophic lateral sclerosis, glioblastoma multiforme, inflammatory bowel disease, antiviral, oncology, parkinson's disease, nonalcoholic steatohepatitis, fibrosis, inflammation, chronic kidney disease, and idiopathic pulmonary fibrosis. It has a collaboration with AstraZeneca to enhance understanding of complex disease biology and identify new targets. The company was founded in 2013 and is headquartered in London, United Kingdom.", "fullTimeEmployees": 363, "companyOfficers": [{"maxAge": 1, "name": "Ms. Joanna  Shields OBE", "age": 59, "title": "CEO & Exec. Director", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": {"raw": 1029095, "fmt": "1.03M", "longFmt": "1,029,095"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Ivan  Griffin Ph.D.", "title": "Co-Founder & COO", "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Nicholas P. Keher", "title": "Chief Financial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Daniel  Neil", "title": "Chief Technology Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Anne  Phelan", "title": "Chief Scientific Officer & Site Head for the Benevolent Cambridge Laboratories", "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Fleur  Wood", "title": "VP of Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Will  Scrimshaw", "title": "Gen. Counsel & Company Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Rajin  Kang", "title": "VP of Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Matthew  Fujisawa", "title": "Sr. VP of Strategy & Corp. Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Anna  Fullerton-Batten", "title": "Chief People Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}